Stay updated with breaking news from Nasdaq Krtx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Free Report) has been given an average rating of “Hold” by the sixteen analysts that are covering the stock, MarketBeat.com reports. Ten investment analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 1-year price target among brokers […]
Headlands Technologies LLC bought a new stake in Karuna Therapeutics, Inc. (NASDAQ:KRTX – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 1,182 shares of the company’s stock, valued at approximately $374,000. Other institutional investors and hedge funds have also made […]
Headlands Technologies LLC bought a new position in shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX – Free Report) during the fourth quarter, Holdings Channel.com reports. The fund bought 1,182 shares of the company’s stock, valued at approximately $374,000. A number of other institutional investors have also recently bought and sold shares of the business. State of […]
AIA Group Ltd bought a new stake in shares of Karuna Therapeutics, Inc. (NASDAQ:KRTX – Free Report) in the 4th quarter, Holdings Channel.com reports. The institutional investor bought 3,630 shares of the company’s stock, valued at approximately $1,149,000. Several other institutional investors also recently made changes to their positions in the stock. FMR LLC grew […]
E Fund Management Co. Ltd. raised its position in Karuna Therapeutics, Inc. (NASDAQ:KRTX – Free Report) by 26.4% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,482 shares of the company’s stock after buying an additional 519 shares […]